LexDanaLexDanabeta
Inventor

Atsushi Suzuki

Inventor
Tokyo, JP

Overview

3→
Patents
2016–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides17%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms17%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
C07DHeterocyclic compounds8%
PatentTitleYear
10,004,739Methods for treating cancer by inhibiting FGFR3/TACC3 fusion protein20189,481,911'Methods for detecting FGFR3/TACC3 fusion genes'20169,464,077'Nitrogen-containing aromatic heterocyclic compound'2016

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2016–2018Patents assigned to ASTELLAS PHARMA INC (3)· patent assignee history
2016Patents assigned to KOTOBUKI PHARMACEUTICAL CO LTD (1)· patent assignee history
2016–2018Based in Tokyo, JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASTELLAS PHARMA INC32016–2018
KOTOBUKI PHARMACEUTICAL CO LTD12016
Locations
LocationPatentsSpan
Tokyo, JP32016–2018